News | August 12, 2014

MUSC Hollings Cancer Center Unveils New TrueBeam STx Installation

TrueBeam STx expands radiation oncology services, offers patients shorter treatment time

August 12, 2014 — New technology installed at the Medical University of South Carolina (MUSC) Hollings Cancer Center in Charleston offers patients a nonsurgical, specialized form of treatment that can be completed in five or fewer outpatient sessions, each lasting 20 minutes or less. The first patient will be treated on Aug. 13.

An investment made in partnership with national radiosurgery provider Alliance Oncology, TrueBeam STx by Varian Medical Systems is an advanced cancer treatment system that treats patients with stereotactic radiosurgery (SRS), a noninvasive method of treating tumors with high-dose radiation precisely matched to the size and shape of the tumor. This pinpoint accuracy minimizes radiation exposure to healthy tissue and allows physicians to customize treatment for different types of cancer, including more complex cases.

“TrueBeam STx will allow us to enhance the patient experience by significantly reducing treatment time to five or fewer visits, which will allow patients who receive the treatment to spend more time with their families and to focus on other activities,” said Joseph Jenrette III, M.D., chairman of the department of radiation oncology at MUSC. “TrueBeam STx can give hope to patients with inoperable or surgically complex tumors, as well as those seeking an alternative to surgery or conventional radiation therapy.”

TrueBeam STx is capable of treating cancerous and noncancerous tumors in the body, including the lung, brain, prostate, spine, liver, pancreas, kidney, bone and eye. It can also treat certain blood vessel abnormalities, as well as trigeminal neuralgia, a neuropathic disorder that causes intense facial pain.

Treatments with TrueBeam STx are available at the MUSC Health main campus in downtown Charleston and will be available in Mount Pleasant in early 2015. An open house will be held at the main hospital on Thursday, Aug. 14, from 4-6 p.m. and will include demonstrations of the new technology.

For more information: www.muschealth.org/radonc

Related Content

Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...
Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill. Interview with Mark Pankuch, Ph.D.

Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill.
 

Feature | April 02, 2019 | Dave Fornell, Editor and A.J. Connell
April 2, 2019 — Here is the list of the most popular content on the Imaging Technology News (ITN) magazine w
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...
Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case
News | Treatment Planning | March 08, 2019
Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the combination of RaySearch's...
Videos | Proton Therapy | March 01, 2019
ITN Associate Editor Jeff Zagoudis speaks with Mark Pankuch, Ph.D., director of physics and dosimetry at the...